PHILADELPHIA--(BUSINESS WIRE)--Feb. 22, 2006--PolyMedix Inc. announced today that it has closed the final round of a financing in which it raised a total of $21.2 million in gross proceeds. The financing consisted of the sale of shares of Series 1 Preferred Stock, which are convertible into the Company’s common stock. In connection with the transaction, PolyMedix completed a merger with another entity in which PolyMedix was the surviving company (in a transaction structure commonly called a “reverse merger”). Fordham Financial of New York served as the placement agent for the offering.
